COMMUNIQUÉS West-GlobeNewswire

Teleflex Announces Third Quarter 2025 Earnings Conference Call Information and Vascular Intervention Investor Virtual Meeting Details
16/10/2025
WAYNE, Pa., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its third quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on [...]
Lexeo Therapeutics Announces Proposed Offering of Common Stock and Pre-Funded Warrants
16/10/2025
NEW YORK, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO) (the “Lexeo”), a clinical stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases, today [...]
Disc Medicine Announces Receipt of FDA Commissioner’s National Priority Voucher (CNPV) for Bitopertin in Erythropoietic Protoporphyria (EPP)
16/10/2025
Disc is seeking accelerated approval of bitopertin for patients aged 12 years and older with EPP The CNPV program is designed to reduce the drug application review process to 1-2 months WATERTOWN, Mass., Oct. 16, 2025 ( [...]
AVITA Medical Announces CEO Transition
17/10/2025
Board Chairman Cary Vance appointed Interim CEO Board member Jan Stern Reed appointed Lead Independent Director Third quarter 2025 preliminary revenue expected to be approximately $17 million VALENCIA, Calif., Oct. 16, [...]
Celebrating 50 Years of Katena: From One Woman’s Vision to a Global Legacy in Ophthalmology
16/10/2025
Honoring five decades of precision, partnership, and innovation that continue to shape the future of eye care PARSIPPANY, N.J., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Corza Medical, a global medical technology company, is [...]
Wounded Warriors Family Support Donates 2025 Ford F-150 Truck to Retired Marines Veteran
16/10/2025
KING OF PRUSSIA, Pa., Oct. 16, 2025 (GLOBE NEWSWIRE) -- A deserving veteran received the life-changing gift of mobility after a considerable donation Tuesday at Topgolf King of Prussia . Wounded Warriors Family Support [...]
AB Science présente les premières données de phase 1 de la combinaison d’AB8939 et du venetoclax dans le traitement de la leucémie myéloïde aiguë réfractaire ou en rechute
16/10/2025
COMMUNIQUÉ DE PRESSE AB SCIENCE PRESENTE LES PREMIÈRES DONNÉES DE PHASE 1 DE LA COMBINAISON D’AB8939 ET DU VENETOCLAX DANS LE TRAITEMENT DE LA LEUCÉMIE MYÉLOÏDE AIGUË RÉFRACTAIRE OU EN RECHUTE Paris, le 16 octobre 2025 [...]
AB Science provides intitial Phase 1 data for the combination of AB8939 with venetoclax for the treatment of refractory or relapsed acute myeloid leukemia
16/10/2025
PRESS RELEASE AB SCIENCE PROVIDES INITIAL PHASE 1 DATA FOR THE COMBINATION OF AB8939 WITH VENETOCLAX FOR THE TREATMENT OF REFRACTORY OR RELAPSED ACUTE MYELOID LEUKEMIA Paris, 16 October 2025, 9pm CET AB Science SA ( [...]
CJ Biomaterials Introduces New PHACT™ PHA Masterbatch for Safer, Stronger, Softer, Home Compostable Spunbond Nonwovens and Staple Fiber
16/10/2025
Innovative solution that is ideal for wipes, diapers, hygiene, and beauty applications, offering enhanced performance and sustainability WOBURN, Mass., Oct. 16, 2025 (GLOBE NEWSWIRE) -- CJ Biomaterials, Inc , a division [...]
Senti Bio to Present at Chardan's 9th Annual Genetic Medicines Conference
16/10/2025
Live webcast presentation on Tuesday, October 21st at 11:35 AM ET SOUTH SAN FRANCISCO, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology [...]
Autonomix Medical, Inc. to Highlight Innovative Nerve-Sensing and Ablation Platform at the 2025 Maxim Growth Summit
16/10/2025
THE WOODLANDS, TX, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today [...]
HCW Biologics’ Scientists to Present Three Posters During the 40th Annual Meeting of the Society for Immunotherapy of Cancer
16/10/2025
Company poster presentations will debut research data of three lead drug candidates constructed with Company’s novel TRBC platform technology MIRAMAR, Fla., Oct. 16, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (“HCWB” [...]
HCW Biologics to Participate in the 2025 Maxim Growth Summit
16/10/2025
MIRAMAR, Fla., Oct. 16, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company”) (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies [...]
Channel Medsystems Strengthens Commercial Leadership Team with Appointments of Tara Murphy as Vice President of Marketing and Paul Russo as Vice President of Sales
16/10/2025
BERKELEY, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Channel Medsystems, Inc., a privately held company dedicated to advancing women’s health with innovative solutions, announced today the appointments of Tara Murphy as [...]
VIRBAC annonce son chiffre d'affaires pour le troisième trimestre 2025
16/10/2025
Croissance soutenue du chiffre d’affaires à fin septembre de +7,8% à taux de change et périmètre constants Relèvement des objectifs financiers annuels de chiffre d’affaires Croissance du chiffre d'affaires attendue [...]
VIRBAC Announces Third Quarter 2025 Sales
16/10/2025
Sustained revenue growth at the end of September of +7.8% at constant exchange rates and scope Upgrade of the full-year revenue guidance Revenue growth now expected to be between 5.5% and 7.5% at constant rates and [...]
Press release: NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES ISSUANCE OF A NEW SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM
16/10/2025
Ghent, Oct. 16, 2025 (GLOBE NEWSWIRE) -- NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES ISSUANCE OF A NEW SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM Ghent, Belgium, 16 [...]
EssilorLuxottica: Chiffre d'affaires T3/9M 2025 - Chiffre d'affaires en hausse de 11,7 % au T3, meilleure performance trimestrielle du Groupe depuis sa création
16/10/2025
Chiffre d'affaires en hausse de 11,7 % au T3 Meilleure performance trimestrielle du Groupe depuis sa création Chiffre d'affaires T3 du Groupe à +11,7 % à taux de change constants 1 , +8,8 % sur les neuf premiers mois [...]
EssilorLuxottica: Q3/9M 2025 Revenue - Revenue up 11.7% in the third quarter, best quarterly performance ever for the Group
16/10/2025
Revenue up 11.7% in the third quarter Best quarterly performance ever for the Group Group’s revenue +11.7% in the third quarter at constant exchange rates 1 , +8.8% in the nine months Wearables major boost, enlarging [...]

Pages